Technology

Covidien DEFINITIVE LE Study Peripheral Artery Disease

October 26, 2012 — Covidien announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of SilverHawk/TurboHawk Peripheral Plaque Excision Systems for the Treatment of I...

The Solitaire Flow Restoration Device from Covidien is among a new generation of devices designed to remove blood clots from blocked brain arteries in patients experiencing an ischemic stroke....

Tilda, Vigila and Celerity leads offer a complete package for physicians to better manage their patients’ individualized needs....

The PrimeWire Prestige Plus is a new fractional flow reserve (FFR) catheter from Volcano Corp. It is the third pressure guidewire the company has introduced in the last three years.

...

A family of cardiovascular research products used to assess cardiac performance and hemodynamics, both in vivo and in vitro is available from iWorks....

Using less lytic drug and offering faster clot dissolution than traditional deep vein thrombosis (DVT) treatments, the EkoSonic MACH4e with Rapid Pulse Modulation (RPM) achieves faster removal of arte...

CRESTOR (rosuvastatin calcium) 20 mg tablets, as an adjunct to diet in adult patients, helps lowered LDL-C, and raise HDL-C to help slow the progression of atherosclerosis.

...

The CYPHER Sirolimus-eluting Coronary Stent offered by Cordis (a Johnson & Johnson company) was the first drug-eluting stent approved for the U.S. market when it was approved by the FDA in 2003.

...